Pashman Stein Fights NJ Decision Freeing Nostrum From Fees
Pashman Stein PC argued before the New Jersey Appellate Division on Tuesday that a lower court improperly freed Nostrum Laboratories Inc. from covering at least $500,000 in fees for a generic-drug...To view the full article, register now.
Already a subscriber? Click here to view full article